Gennex Laboratories

GENNEX
Price
-- --
 
Nano Cap
₹260 Cr.
Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediates.The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine.
Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediates.Th… More
Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediates.The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine. Less
Low
7.05
52W Range
High
17.25
PE
12.39
Sector PE
30.5
P/B
1.17
Div.Yield
--
ROE
9.71%
EBIDTA
8.99
ROCE
11.9
EPS
0.18
WhatsApp

Get instant stock alerts
  • Share Price
  • Financials
  • Revenue mix
  • Shareholdings
  • Peers
  • Forensics
Niche index constructed using market cap and revenue exposure of companies in this sector

Coming soon

  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

Yearly | Quarterly
View Detailed Summary View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

GENNEX
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    GENNEX
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info

    Shareholdings

    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers

    Forensics

    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    Promoter Pledge Creation
    Jun 10, 2026
    Gennex Laboratories Says Unit Got Andhra Pradesh Government Approval To Manufacture Additional Products
    Oct 28, 2024
    Gennex Laboratories To Consider Fundraising By Way Of Preferential Issue
    Nov 29, 2023
    Gennex Laboratories To Consider Preferential Issue Of Shares
    Nov 20, 2023
    Gennex Laboratories Unit Received License From Government Of Andhra Pradesh
    Jun 01, 2023
    Gennex Laboratories Unit Got CFO Approval From Pollution Control Board
    May 31, 2023
    Events:
    Announcement Date
    May 30, 2026
    Announcement Date
    Feb 14, 2026
    Announcement Date
    Nov 14, 2025
    Announcement Date
    Sep 08, 2025
    Announcement Date
    Aug 14, 2025
    Announcement Date
    May 30, 2025
    Announcement Date
    Feb 14, 2025
    Announcement Date
    Nov 14, 2024
    Announcement Date
    Sep 07, 2024
    Announcement Date
    Aug 14, 2024
    Announcement Date
    Feb 14, 2024
    Announcement Date
    Nov 14, 2023
    Announcement Date
    Sep 11, 2023
    Announcement Date
    Aug 14, 2023
    Announcement Date
    May 30, 2023
    Announcement Date
    Feb 14, 2023
    Announcement Date
    Nov 14, 2022
    Announcement Date
    Sep 09, 2022
    Announcement Date
    Aug 12, 2022
    Rights
    1 rights eligible for every 2 shares held.
    Ex Date
    Jul 21, 2022
    Announcement Date
    May 30, 2022
    Announcement Date
    Feb 14, 2022
    Announcement Date
    Nov 13, 2021
    Announcement Date
    Aug 13, 2021
    Announcement Date
    Jun 30, 2021
    Announcement Date
    Feb 13, 2021
    Announcement Date
    Nov 12, 2020
    Announcement Date
    Sep 15, 2020
    Announcement Date
    Jul 30, 2020
    Announcement Date
    Jun 30, 2020
    Announcement Date
    Feb 14, 2020

    More Nano Cap Ideas

    See similar 'Nano' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List